Vaxcyte公布公开募股及5亿美元2032年到期可转换票据定价

投资观察
Oct 07

10月6日(路透社)- Vaxcyte公司::*Vaxcyte宣布同步公开募股普通股、预融资认股权证及可转换优先票据的定价*Vaxcyte——宣布公开募股及5亿美元2032年到期可转换票据的定价*Vaxcyte——普通股发行价为每股64美元;预融资认股权证定价64美元;行权价0.001美元

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10